TrialClinical pharmacokinetics2019

Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis.

Amit Taneja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.